Media Room

11.04.2018

Bioequivalence study of a drug for HIV patients

An open-label, randomize, two-period, crossover study in healthy volunteers. Over 90% of volunteers were enrolled during the first two weeks. The target enrollment rates were reached within 21 days.

Thank you for your request!
Our team will respond to you within 24 hours.